Health & Wellness: Insights for a Better Life

Stay informed with the latest health news, medical breakthroughs, and wellness trends. From expert advice to scientific discoveries, explore updates that help you lead a healthier, more informed life.

Australia's Automated Aged Care Assessment Tool Under Review After Thousands Left Without Adequate Support

Health & Wellness: Insights for a Better Life | BalVoi

Australia's Automated Aged Care Assessment Tool Under Review After Thousands Left Without Adequate Support
Australia's government has announced an independent review of its Support At Home Integrated Assessment Tool after widespread reports that the automated aged care system has left many older Australians with reduced support coverage. Sydney resident Karlene McCabe, whose partner has a brain tumour, launched a petition that gathered over 10,000 signatures after the couple's support tier was reduced by the automated system. The review will report to parliament by mid-2027, with new case review options available from January 2027. Lawmakers and advocacy groups have called for greater transparency and human oversight in the algorithm-based assessment process.
Read
FSSAI Issues Notices to Nestle India and Hindustan Unilever Over Labelling and Advertising Non-Compliance
India's Food Safety and Standards Authority (FSSAI) has issued formal notices to Nestle India and Hindustan Unilever, citing misleading claims and regulatory non-compliance on multiple products including Nescafé beverages, Nestle Resource Renal Vanilla powder, and Horlicks Women's Plus and Mother's Plus products. The regulator also cancelled the licence of Bala Ji Food Products and suspended the licence of Sukhdarshan Pharma following inspection findings.
Read
India Caps Trade Margins on 137 Anti-Cancer Drugs, Prices May Drop Up to 70%
India's National Pharmaceutical Pricing Authority has capped trade margins at 30% on 137 non-scheduled anti-cancer drugs, including Pembrolizumab, Osimertinib, Bevacizumab, and Durvalumab, with revised maximum retail prices effective November 9, 2026. The move, issued under Gazette notification S.O. 5690(E) dated October 17, 2026, is expected to reduce prices by up to 70%. The order builds on a 2019 pilot exercise and follows recommendations from an Expert Committee comprising oncologists, medical specialists, and government officers. Manufacturers are required to comply with specific pricing formulas, reporting timelines, and production safeguards, while hospitals and retailers must display and enforce the revised prices.
Read
FSSAI Issues Notices to Nestle India and HUL Over Misleading Food Product Claims
India's Food Safety and Standards Authority (FSSAI) has issued notices to Nestle India and Hindustan Unilever Ltd (HUL) over misleading claims and non-compliances identified on the packaging and advertising of several food and nutrition products. HUL received notices concerning its Horlicks Women's Plus and Horlicks Mother's Plus Kesar products, with multiple health claims flagged as misleading or in violation of food safety regulations. Nestle India received notices related to its Nescafe Ready-to-Drink product range over inconsistent labelling descriptions, and separately for marketing a renal dietary product without obtaining the required prior regulatory approval. Both companies have been directed to submit responses within stipulated timeframes.
Read
Indian Government to Cap Trade Margins on 137 Anti-Cancer Drugs, Cutting Prices by Up to 70%
India's National Pharmaceutical Pricing Authority (NPPA) has capped trade margins at 30 per cent for 137 non-scheduled anti-cancer drugs, with maximum retail prices projected to fall by up to 70 per cent. The revised pricing takes effect on November 9, 2026, and covers immunotherapy drugs used for over 20 cancer types, including Denosumab, Bevacizumab, Pembrolizumab, and others. Compliance will be monitored by state drug controllers, and patients can verify new prices via the Pharma Sahi Daam app and NPPA website.
Read

Health & Wellness: Insights for a Better Life

Health & Wellness: Insights for a Better Life

Australia's Automated Aged Care Assessment Tool Under Review After Thousands Left Without Adequate Support

Health & Wellness: Insights for a Better Life

Australia's Automated Aged Care Assessment Tool Under Review After Thousands Left Without Adequate Support

FSSAI Issues Notices to Nestle India and Hindustan Unilever Over Labelling and Advertising Non-Compliance

India Caps Trade Margins on 137 Anti-Cancer Drugs, Prices May Drop Up to 70%

FSSAI Issues Notices to Nestle India and HUL Over Misleading Food Product Claims

Indian Government to Cap Trade Margins on 137 Anti-Cancer Drugs, Cutting Prices by Up to 70%

Diet Quality May Influence How Genetic Risk Affects Cholesterol Levels, Chennai Study Finds